Home » Gene Synthesis & Molecular Biology Services » Off-the-Shelf Plasmids » pGS-scAAV-ITR141-Kan-CAG
Manual
COAs
Sequencing

pGS-scAAV-ITR141-Kan-CAG

A GenScript-innovative self-complementary AAV (scAAV) transfer vector engineered with superior ITR stability and high plasmid yield. This vector includes a truncated AAV2 ITR sequence, a kanamycin resistance gene, the CAG promoter for strong and ubiquitous transgene expression, and an SV40 polyadenylation signal. Ideal for versatile gene therapy applications in therapeutic development pipelines.
$1299.00
RP-B00038-10

Ask us a question
Product Introduction
Description A GenScript-innovative self-complementary AAV (scAAV) transfer vector engineered with superior ITR stability and high plasmid yield. This vector includes a truncated AAV2 ITR sequence, a kanamycin resistance gene, the CAG promoter for strong and ubiquitous transgene expression, and an SV40 polyadenylation signal. Ideal for versatile gene therapy applications in therapeutic development pipelines. More information
Back

Product Specification
Product Type AAV Proprietary Vector, scAAV
Bacteria Resistance Kanamycin
Promoter CAG
Back

Quality Control Specifications
Appearance Clear, colorless, and free from precipitates or foreign particles
Homogeneity (Supercoil) Predominantly Supercoil
Endotoxin Level ≤0.01 EU/μg
Residual RNA Not detectable at 200 ng
E. coli Genomic DNA <15% of all bands via AGE
Restriction Analysis Conforming to reference pattern
Sequencing 100% Sequence Accuracy
Back

Storage
Storage Conditions Store at -20°C
Format 10µg, lyophilized
Back

Disclaimer
Disclaimer For Research Use Only. Not for use in human therapeutics or diagnostic procedures. GenScript Proprietary Vector: Use is subject to terms and conditions ─ view details here: www.genscript.com/genscript-proprietary-vector-terms.html
Back